Surface Oncology, Inc.
SURF · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $30,000 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $30,000 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | $13,831 | $13,777 | $15,288 | $16,894 |
| G&A Expenses | $8,576 | $5,886 | $5,896 | $6,004 |
| SG&A Expenses | $8,576 | $5,886 | $5,896 | $6,004 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22,407 | $19,663 | $21,184 | $22,898 |
| Operating Income | -$25,641 | -$19,663 | -$21,184 | -$22,898 |
| % Margin | – | – | -70.6% | – |
| Other Income/Exp. Net | -$2,551 | -$78 | -$149 | -$342 |
| Pre-Tax Income | -$28,192 | -$19,741 | -$21,333 | -$23,240 |
| Tax Expense | $0 | $1,010 | $149 | $342 |
| Net Income | -$28,192 | -$20,751 | -$21,482 | -$23,582 |
| % Margin | – | – | -71.6% | – |
| EPS | -0.46 | -0.34 | -0.35 | -0.4 |
| % Growth | -35.3% | 2.9% | 12.5% | – |
| EPS Diluted | -0.46 | -0.34 | -0.35 | -0.4 |
| Weighted Avg Shares Out | 60,718 | 60,628 | 60,563 | 59,054 |
| Weighted Avg Shares Out Dil | 60,718 | 60,628 | 60,563 | 59,054 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,108 | $932 | $149 | $829 |
| Depreciation & Amortization | $1,989 | $1,172 | $331 | $833 |
| EBITDA | -$23,095 | -$18,491 | -$29,072 | -$22,065 |
| % Margin | – | – | -96.9% | – |